Inotropic agents are the mainstay of treatment for heart failure and cardiogenic shock, are routinely used in ICUs and are considered by physicians for treatment of chronic heart failure. count. Despite the effect of increasing the stroke volume of the heart, many studies have shown that inotropic drugs can increase the risk of death due to increased heart rate, arrhythmia, myocardial ischemia. New generation inotropic drugs have opened up new prospects, helping to increase myocardial contractility, reduce side effects, and prolong patient's life.